ARTG 237858Medicine administration kit, percutaneous, medicated, single-use
ARTG ID: 237858 · Pfizer Australia Pty Ltd · Pfizer Manufacturing Belgium · Class IIa · Started May 15, 2015
Good Name: Pfizer Australia Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use
- Risk Class
- Class IIa
- Product Type
- Procedure Pack
- ARTG Category
- General
- ARTG ID
- 237858
- Start Date
- May 15, 2015
- Effective Date
- May 15, 2015
- Country
- Belgium
- Address
- Rijksweg 12, Puurs-Sint-Amands, 2870
Single use device for intracavernosal self-administration of medicine. It is for the treatment of erectile dysfunction in adult males. It may also be used as adjunct to other diagnostic tests in the diagnosis of erectile dysfunction. The Caverject Procedure Pack is supplied with a vial containing Caverject powder for injection, a diluent syringe, needles and alcohol swabs. The Caverject Impulse Procedure Pack is supplied with a vial containing Caverject powder for injection, a diluent dual chamber cartridge, needles and alcohol swabs.
Access comprehensive regulatory information for Medicine administration kit, percutaneous, medicated, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 237858 and sponsored by Pfizer Australia Pty Ltd, manufactured by Pfizer Manufacturing Belgium in Belgium. The device registration started on May 15, 2015.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.